Ra Pharmaceuticals, Inc. Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ra Pharmaceuticals, Inc. for May 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 25 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 25.01 | 17,451 | 436,364 | 2,391,952 | 2.4 M to 2.4 M (-0.72 %) |
May 22 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 25.50 | 9,019 | 229,964 | 2,409,403 | 2.4 M to 2.4 M (-0.37 %) |
May 18 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 25.51 | 22,534 | 574,901 | 2,418,422 | 2.4 M to 2.4 M (-0.92 %) |
May 18 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 26.33 | 20,081 | 528,725 | 2,440,956 | 2.5 M to 2.4 M (-0.82 %) |
May 02 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 20.91 | 7,778 | 162,658 | 2,461,037 | 2.5 M to 2.5 M (-0.32 %) |
May 02 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 20.86 | 7,847 | 163,670 | 2,468,815 | 2.5 M to 2.5 M (-0.32 %) |
May 02 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 20.96 | 57,844 | 1,212,306 | 2,476,662 | 2.5 M to 2.5 M (-2.28 %) |
May 02 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 20.93 | 5,398 | 113,000 | 2,534,506 | 2.5 M to 2.5 M (-0.21 %) |
May 02 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 21.04 | 4,999 | 105,160 | 2,539,904 | 2.5 M to 2.5 M (-0.20 %) |
May 02 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 21.86 | 749 | 16,370 | 2,544,903 | 2.5 M to 2.5 M (-0.03 %) |